Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$43.77 - $63.22 $420,585 - $607,480
-9,609 Closed
0 $0
Q4 2021

Feb 15, 2022

SELL
$49.55 - $74.59 $9,563 - $14,395
-193 Reduced 1.97%
9,609 $510,000
Q3 2021

Nov 15, 2021

BUY
$57.6 - $70.59 $76,665 - $93,955
1,331 Added 15.71%
9,802 $692,000
Q2 2021

Aug 16, 2021

BUY
$51.81 - $118.56 $169,263 - $387,335
3,267 Added 62.78%
8,471 $565,000
Q4 2020

Feb 12, 2021

BUY
$88.75 - $119.95 $14,643 - $19,791
165 Added 3.27%
5,204 $618,000
Q3 2020

Nov 13, 2020

BUY
$75.65 - $93.58 $107,574 - $133,070
1,422 Added 39.31%
5,039 $440,000
Q2 2020

Aug 13, 2020

SELL
$84.96 - $118.91 $3,313 - $4,637
-39 Reduced 1.07%
3,617 $324,000
Q1 2020

May 15, 2020

BUY
$74.34 - $121.82 $142,286 - $233,163
1,914 Added 109.87%
3,656 $364,000
Q4 2019

Feb 14, 2020

BUY
$114.37 - $129.46 $199,232 - $225,519
1,742 New
1,742 $200,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.51B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Allstate Corp Portfolio

Follow Allstate Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.